Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

News Conference News TCT 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Caitlin E. Cox

October 31, 2024

Presentation TCT 2024

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Presenter: Hongbo Yang

October 30, 2024

News Conference News TCT 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Yael L. Maxwell

October 29, 2024

Presentation TCT 2024

TCT 242: Prospective Validation of the ARC-HBR, PRECISE-DAPT, and PARIS Risk Prediction Model in the All-Comer PIONEER IV Trial

Presenter: TsungYing Tsai

October 28, 2024

Presentation TCT 2024

From ARC-HBR and PRECISE-DAPT to PRECISE-2: Development and Validation of a Novel Universal Bleeding Risk Score

Presenter: Marco Valgimigli

October 27, 2024

Presentation TCT 2024

TCT 234: Sex Differences in the Safety and Efficacy of Short-term DAPT Versus DAPT De-escalation After Percutaneous Coronary Intervention

Presenter: Donna Lin

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Advertisement

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

TCT 242: Prospective Validation of the ARC-HBR, PRECISE-DAPT, and PARIS Risk Prediction Model in the All-Comer PIONEER IV Trial

From ARC-HBR and PRECISE-DAPT to PRECISE-2: Development and Validation of a Novel Universal Bleeding Risk Score

TCT 234: Sex Differences in the Safety and Efficacy of Short-term DAPT Versus DAPT De-escalation After Percutaneous Coronary Intervention

What’s Going to Be Big at TCT 2024?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content